Clinical laboratory reference values in adults in Kisumu County, Western Kenya; hematology, chemistry and CD4.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
15
05
2020
accepted:
15
03
2021
entrez:
30
3
2021
pubmed:
31
3
2021
medline:
14
10
2021
Statut:
epublish
Résumé
Clinical laboratory reference intervals (RIs) are essential for diagnosing and managing patients in routine clinical care as well as establishing eligibility criteria and defining adverse events in clinical trials, but may vary by age, gender, genetics, nutrition and geographic location. It is, therefore, critical to establish region-specific reference values in order to inform clinical decision-making. We analyzed data from a prospective observational HIV incidence cohort study in Kombewa, Kenya. Study participants were healthy males and females, aged 18-35 years, without HIV. Median and 95% reference values (2.5th percentile to 97.5th percentile) were calculated for laboratory parameters including hematology, chemistry studies, and CD4 T cell count. Standard Deviation Ratios (SDR) and Bias Ratios (BR) are presented as measures of effect magnitude. Findings were compared with those from the United States and other Kenyan studies. A total of 299 participants were analyzed with a median age of 24 years (interquartile range: 21-28). Ratio of males to females was 0.9:1. Hemoglobin range (2.5th-97.5th percentiles) was 12.0-17.9 g/dL and 9.5-15.3 g/dL in men and women respectively. In the cohort, MCV range was 59-95fL, WBC 3.7-9.2×103/μL, and platelet 154-401×103/μL. Chemistry values were higher in males; the creatinine RI was 59-103 μmol/L in males vs. 46-76 μmol/L in females (BRUL>.3); and the alanine transferase range was 8.8-45.3 U/L in males vs. 7.5-36.8 U/L in females (SDR>.3). The overall CD4 T cell count RI was 491-1381 cells/μL. Some parameters including hemoglobin, neutrophil, creatinine and ALT varied with that from prior studies in Kenya and the US. This study not only provides clinical reference intervals for a population in Kisumu County but also highlights the variations in comparable settings, accentuating the requirement for region-specific reference values to improve patient care, scientific validity, and quality of clinical trials in Africa.
Sections du résumé
BACKGROUND
Clinical laboratory reference intervals (RIs) are essential for diagnosing and managing patients in routine clinical care as well as establishing eligibility criteria and defining adverse events in clinical trials, but may vary by age, gender, genetics, nutrition and geographic location. It is, therefore, critical to establish region-specific reference values in order to inform clinical decision-making.
METHODS
We analyzed data from a prospective observational HIV incidence cohort study in Kombewa, Kenya. Study participants were healthy males and females, aged 18-35 years, without HIV. Median and 95% reference values (2.5th percentile to 97.5th percentile) were calculated for laboratory parameters including hematology, chemistry studies, and CD4 T cell count. Standard Deviation Ratios (SDR) and Bias Ratios (BR) are presented as measures of effect magnitude. Findings were compared with those from the United States and other Kenyan studies.
RESULTS
A total of 299 participants were analyzed with a median age of 24 years (interquartile range: 21-28). Ratio of males to females was 0.9:1. Hemoglobin range (2.5th-97.5th percentiles) was 12.0-17.9 g/dL and 9.5-15.3 g/dL in men and women respectively. In the cohort, MCV range was 59-95fL, WBC 3.7-9.2×103/μL, and platelet 154-401×103/μL. Chemistry values were higher in males; the creatinine RI was 59-103 μmol/L in males vs. 46-76 μmol/L in females (BRUL>.3); and the alanine transferase range was 8.8-45.3 U/L in males vs. 7.5-36.8 U/L in females (SDR>.3). The overall CD4 T cell count RI was 491-1381 cells/μL. Some parameters including hemoglobin, neutrophil, creatinine and ALT varied with that from prior studies in Kenya and the US.
CONCLUSION
This study not only provides clinical reference intervals for a population in Kisumu County but also highlights the variations in comparable settings, accentuating the requirement for region-specific reference values to improve patient care, scientific validity, and quality of clinical trials in Africa.
Identifiants
pubmed: 33784358
doi: 10.1371/journal.pone.0249259
pii: PONE-D-20-14555
pmc: PMC8009432
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0249259Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Am J Phys Anthropol. 1998 Jul;106(3):385-400
pubmed: 9696153
J Clin Pathol. 1996 Aug;49(8):664-6
pubmed: 8881919
PLoS One. 2020 Jul 9;15(7):e0235234
pubmed: 32645006
Scand J Haematol. 1985 Jul;35(1):77-9
pubmed: 4048863
PLoS One. 2015 Apr 13;10(4):e0123140
pubmed: 25874714
PLoS One. 2014 May 15;9(5):e93919
pubmed: 24832127
Inflamm Bowel Dis. 2013 Jul;19(8):1609-16
pubmed: 23644823
Am J Physiol Endocrinol Metab. 2001 Dec;281(6):E1172-81
pubmed: 11701431
Clin Diagn Lab Immunol. 2004 Jan;11(1):168-73
pubmed: 14715565
PLoS One. 2009;4(2):e4401
pubmed: 19197365
PLoS One. 2021 Mar 19;16(3):e0236772
pubmed: 33740794
Clin Diagn Lab Immunol. 1999 May;6(3):410-4
pubmed: 10225845
PLoS One. 2018 Jun 7;13(6):e0198444
pubmed: 29879171
PLoS One. 2011;6(6):e21040
pubmed: 21713038
Clin Diagn Lab Immunol. 2003 May;10(3):443-5
pubmed: 12738646
PLoS One. 2008 Oct 03;3(10):e3327
pubmed: 18833329
Vaccine. 2008 May 23;26(22):2788-95
pubmed: 18440674
PLoS One. 2014 May 14;9(5):e97391
pubmed: 24827458
J Int Assoc Provid AIDS Care. 2017 Jul/Aug;16(4):359-365
pubmed: 24842948
Trop Med Int Health. 2008 May;13(5):612-25
pubmed: 18331386
Platelets. 2013;24(5):348-51
pubmed: 22738419
Clin Immunol. 2005 Aug;116(2):192-7
pubmed: 15993366
Am Fam Physician. 2017 Dec 1;96(11):709-715
pubmed: 29431403
Clin Infect Dis. 2019 Aug 1;69(4):639-647
pubmed: 30476001
Curr Mol Med. 2005 Dec;5(8):761-72
pubmed: 16375711
J Clin Pathol. 1984 Feb;37(2):188-93
pubmed: 6693578
N Engl J Med. 2004 Oct 7;351(15):1548-63
pubmed: 15470219
Clin Diagn Lab Immunol. 2001 Nov;8(6):1171-6
pubmed: 11687459
PLoS One. 2011 Jan 21;6(1):e14580
pubmed: 21283743
Clin Diagn Lab Immunol. 2004 Jan;11(1):29-34
pubmed: 14715541
Am J Trop Med Hyg. 2021 Jan;104(1):12-25
pubmed: 33241783
Clin Vaccine Immunol. 2007 Jun;14(6):782-4
pubmed: 17442846
Eur J Haematol. 2004 Mar;72(3):203-12
pubmed: 14962239
Genitourin Med. 1996 Feb;72(1):27-31
pubmed: 8655163
Clin Chem Lab Med. 2010 Nov;48(11):1537-51
pubmed: 21062226
Haematologica. 1999 Jun;84(6):499-504
pubmed: 10366792
Parasitol Res. 2006 Sep;99(4):500-4
pubmed: 16572338
Lancet. 2000 Oct 7;356(9237):1255-9
pubmed: 11072960
J Health Popul Nutr. 2013 Mar;31(1):58-64
pubmed: 23617205
Postgrad Med J. 2007 Mar;83(977):148-51
pubmed: 17344565
Int Health. 2016 May;8(3):157-8
pubmed: 27178673
Am J Physiol. 1966 Feb;210(2):315-20
pubmed: 5901469
PLoS Negl Trop Dis. 2014 Apr 03;8(4):e2784
pubmed: 24699502
Mech Ageing Dev. 2006 Mar;127(3):274-81
pubmed: 16352331
Am J Trop Med Hyg. 2003 Sep;69(3):318-23
pubmed: 14628951
Open AIDS J. 2011;5:74-9
pubmed: 21892376